We are BrainsWay

What BrainsWay is all about

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain four FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy.

Current indications include major depressive disorder, obsessive-compulsive disorder, smoking addiction, and anxious depression. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA, Cresskill, NJ and Jerusalem, Israel, BrainsWay is committed to increasing global awareness and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit the news page.

Our Leadership Team

Christopher von Jako

Christopher R. von Jako, PhD

President and Chief Executive Officer (CEO)

Scott Areglado, Senior VP and Chief Financial Officer (CFO)

Scott Areglado

Senior VP and Chief Financial Officer (CFO)

Hadar Levy - Chief Financial Officer at BrainsWay

Hadar Levy

Senior VP, Chief Operating Officer (COO)

Moria Ankry

Moria Ben Soussan (Ankri)

VP of Research & Development

Chris Boyer

Christopher Boyer

VP of Global Marketing

Amit Ginou - VP of Field & Clinical Operations at BrainsWay

Amit Ginou

VP and Site Manager

Eric Hirt

VP of US Sales

Menachem C. Klein, Esq. VP, General Counsel and Corporate Secretary

Menachem C. Klein, Esq.

VP, General Counsel and Corporate Secretary

Yiftach Roth, PhD - Founder of BrainsWay

Yiftach Roth, PhD

Chief Scientific Officer (CSO)

Joachim Seidel, PhD

VP of Corporate Development and Strategy

Aron Tendler MD

Aron Tendler, MD, C.BSM

Chief Medical Officer (CMO)

David Zacut - Director at BrainsWay

David Zacut, MD

Chairman of the Board

Yossi Ben Shalom

Yossi Ben Shalom

Board Director

Avner Hagai - Director at BrainsWay

Avner Hagai

Board Director

Avner Lushi

Avner Lushi

Board Director

Eti Mitrany - Director at BrainsWay

Eti Mitrany

Board Director

Karen Sarid - Director at BrainsWay

Karen Sarid

Board Director

Avraham Zangen, PhD - Sits on the Scientific Advisory Board at BrainsWay

Abraham Zangen, PhD

Board Director

Avner Hagai - Director at BrainsWay

Avner Hagai

Board Director

Yiftach Roth, PhD - Founder of BrainsWay

Yiftach Roth, PhD

Chief Scientific Officer (CSO)

David Zacut - Director at BrainsWay

David Zacut, MD

Chairman of the Board

Avraham Zangen, PhD - Sits on the Scientific Advisory Board at BrainsWay

Abraham Zangen, PhD

Board Director

Join Us

A career with BrainsWay is more than just a job. It’s personal. As a leader in non-invasive brain stimulation we’re deeply committed to help patients who suffer from brain disorders. If you’re a natural problem-solver with the imagination, courage and spirit to make a meaningful difference, BrainsWay is where you want to build your career.

Current Open Positions

    News & Events

    See all the latest news, events and in the media BrainsWay has to offer, and everything in-between.

    May 17, 2022

    Sun Valley throws open its mental health doors

    Live the Sun Valley Experience Mental Health Fair held by Sun Valley Medical Center and Sun Valley Research...

    May 11, 2022

    BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

    Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30...

    May 9, 2022

    BrainsWay Appoints Eric Hirt as Vice President of U.S. Sales

    Veteran Medical Device Industry Sales and Marketing Executive Has Over 20 Years of Experience BURLINGTON,...